Top news
Covid-19: Johnson & Johnson to Resume Its Vaccine Rollout in Europe (Published 2021)
By Keith Collins, Sharon LaFraniere & Matina Stevis-Gridneff
The race to untangle the secrets of rare, severe blood clots after Johnson & Johnson vaccination
By Carolyn Johnson
The Latest On The COVID-19 Vaccination Effort In The U.S.
By Paige Osburn
All coverage
EU regulator finds possible blood clot link with J&J vaccine, but says benefits outweigh risks
By Sílvia Amaro
EU Calls for J&J Covid-19 Vaccine Warning on Blood Clots, but Says Benefits Outweigh Risks
By Eric Sylvers & Thomas M. Burton
More Than Half Of U.S. Adults Have Gotten At Least One COVID-19 Vaccine Dose
By Matthew S. Schwartz
All U.S. adults now eligible for COVID-19 vaccine
By Fadel Allassan
Possible link between J&J Covid vaccine and rare blood clots, EU regulator finds
By Jon Henley & Ian Sample
All U.S. States Have Met Biden's Vaccine Expansion Deadline
By Eileen Sullivan, Madeleine Ngo & Emily Anthes
J&J Covid-19 Vaccine Pause Driven by Risk of Mistreating Blood Clots - WSJ
By Betsy McKay & Thomas M. Burton
Johnson & Johnson said blood clots have been reported with all Covid-19 vaccines. The author of the study they cited says they're wrong.
By Elizabeth Cohen
Fauci says U.S. will likely resume use of J&J Covid vaccine with a warning or restriction
By Emma Newburger
J&J to resume rollout of COVID-19 vaccine in Europe with safety warning
By Manas Mishra & Carl O'Donnell